Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ T-cell clones in vitro.
about
Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticlesMaintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments.N-linked oligosaccharides can protect target cells from the lysis mediated by NK cells but not by cytotoxic T lymphocytes: role of NKG2-A.
P2860
Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ T-cell clones in vitro.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Combination of human cytomegal ...... o CD4+ T-cell clones in vitro.
@en
type
label
Combination of human cytomegal ...... o CD4+ T-cell clones in vitro.
@en
prefLabel
Combination of human cytomegal ...... o CD4+ T-cell clones in vitro.
@en
P2093
P50
P1433
P1476
Combination of human cytomegal ...... to CD4+ T-cell clones in vitro
@en
P2093
P304
P356
10.1016/0264-410X(95)00233-Q
P407
P577
1996-04-01T00:00:00Z